Table of Contents
1. Introduction
1.1 ELISA Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 ELISA Market Snapshot
2.2 ELISA Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 ELISA Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 ELISA Market Size By Product Type
2.3.2 ELISA Market Size By Application
2.3.3 ELISA Market Size By End User
2.4 ELISA Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. ELISA Market Overview
3.1 ELISA Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key ELISA Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting ELISA Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers (Antibodies, Reagents, Microplates)
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent In Vitro Diagnostics (IVD) Market Overview
3.7 ELISA Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing Analysis & Forecast
4.1.1 Overview
4.1.2 Average Kit Price by ELISA Type (Direct, Indirect, Sandwich, Competitive)
4.1.3 Price Benchmarking by Key ELISA Manufacturers
4.1.4 Regional Pricing Differences and Reimbursement Metrics
4.1.5 Emerging Pricing Models (High-Throughput Automation, Bulk Reagent Kits)
4.2 Regulatory & Compliance Landscape
4.2.1 Overview
4.2.2 Compliance with IVDR (EU) and FDA 510(k) Clearance for ELISA Kits
4.2.3 CLIA Waiver and Laboratory Certification Requirements
4.2.4 Policies Promoting Assay Standardization and Quality Control
4.2.5 Strategic Guidelines for Compliance and Risk Management in Diagnostics
4.3 Technology & Innovation Metrics
4.3.1 Overview
4.3.2 Adoption Rate of Automated ELISA Workstations and Microplate Readers
4.3.3 Investment in Multiplex ELISA and Chemiluminescence Technologies
4.3.4 Patent Filings and Technological Innovations in ELISA Detection Systems
4.3.5 Emerging Trends: Digital ELISA (Simoa), AI-Assisted Data Analysis, and POC ELISA Devices
4.4 Operational & Performance Metrics
4.4.1 Overview
4.4.2 Number of ELISA Tests Performed Annually by Region
4.4.3 Throughput Capacity and Assay Turnaround Time by Lab Type
4.4.4 Average Sensitivity and Specificity Benchmarks by ELISA Type
4.4.5 Quality Control Failure Rates and Batch-to-Batch Consistency Metrics
4.5 Investment & Strategic Activity
4.5.1 Overview
4.5.2 Venture Capital and Private Equity Investments in ELISA & Immunoassay Companies
4.5.3 Key M&A Activity and Strategic Partnerships
4.5.4 Collaborations Between Diagnostic OEMs, Research Institutes, and CROs
4.5.5 Emerging Innovation Hubs and R&D Centers for Next-Gen Immunoassays
5. ELISA Market Segmental Analysis & Forecast, By Product Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Direct ELISA
5.2.1 Key Trends
5.2.2 ELISA Market Size & Forecast, 2022–2035
5.3 Indirect ELISA
5.4 Sandwich ELISA
5.5 Competitive ELISA
5.6 Others
6. ELISA Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Clinical Diagnostics
6.2.1 Key Trends
6.2.2 ELISA Market Size & Forecast, 2022–2035
6.3 Research Laboratories
6.4 Pharmaceutical & Biotech Testing
6.5 Food & Beverage Testing
6.6 Environmental Testing
6.7 Others
7. ELISA Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Hospitals & Clinics
7.2.1 Key Trends
7.2.2 ELISA Market Size & Forecast, 2022–2035
7.3 Diagnostic Laboratories
7.4 Research Institutions
7.5 Pharmaceutical Companies
7.6 Others
8. ELISA Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 ELISA Market Size & Forecast, By Product Type, 2022–2035
8.2.3 ELISA Market Size & Forecast, By Application, 2022–2035
8.2.4 ELISA Market Size & Forecast, By End User, 2022–2035
8.2.5 ELISA Market Size & Forecast, By Country, 2022–2035
8.2.5.1 USA
8.2.5.2 Canada
8.3 Europe
8.3.1 Key Trends
8.3.2 ELISA Market Size & Forecast, By Product Type, 2022–2035
8.3.3 ELISA Market Size & Forecast, By Application, 2022–2035
8.3.4 ELISA Market Size & Forecast, By End User, 2022–2035
8.3.5 ELISA Market Size & Forecast, By Country, 2022–2035
8.3.5.1 Germany
8.3.5.2 UK
8.3.5.3 France
8.3.5.4 Italy
8.3.5.5 Spain
8.3.5.6 Russia
8.3.5.7 Poland
8.3.5.8 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 ELISA Market Size & Forecast, By Product Type, 2022–2035
8.4.3 ELISA Market Size & Forecast, By Application, 2022–2035
8.4.4 ELISA Market Size & Forecast, By End User, 2022–2035
8.4.5 ELISA Market Size & Forecast, By Country, 2022–2035
8.4.5.1 China
8.4.5.2 India
8.4.5.3 Japan
8.4.5.4 South Korea
8.4.5.5 Australia
8.4.5.6 ASEAN Countries
8.4.5.7 Rest of Asia-Pacific
8.5 Latin America
8.5.1 Key Trends
8.5.2 ELISA Market Size & Forecast, By Product Type, 2022–2035
8.5.3 ELISA Market Size & Forecast, By Application, 2022–2035
8.5.4 ELISA Market Size & Forecast, By End User, 2022–2035
8.5.5 ELISA Market Size & Forecast, By Country, 2022–2035
8.5.5.1 Brazil
8.5.5.2 Argentina
8.5.5.3 Mexico
8.5.5.4 Colombia
8.5.5.5 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 ELISA Market Size & Forecast, By Product Type, 2022–2035
8.6.3 ELISA Market Size & Forecast, By Application, 2022–2035
8.6.4 ELISA Market Size & Forecast, By End User, 2022–2035
8.6.5 ELISA Market Size & Forecast, By Country, 2022–2035
8.6.5.1 UAE
8.6.5.2 Saudi Arabia
8.6.5.3 Qatar
8.6.5.4 Egypt
8.6.5.5 South Africa
8.6.5.6 Rest of Middle East & Africa
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Key Strategies Adopted (%), By Key Players, 2025
9.2.2 Year-Wise Strategies & Development, 2022–2025
9.2.3 Number Of Strategies Adopted By Key Players, 2025
9.3 ELISA Market Share Analysis, 2025
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Thermo Fisher Scientific Inc.
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 SWOT Analysis
9.6.2 Bio-Rad Laboratories, Inc.
9.6.3 Agilent Technologies, Inc.
9.6.4 Merck KGaA
9.6.5 PerkinElmer, Inc.
9.6.6 Abbott Laboratories
9.6.7 Roche Diagnostics
9.6.8 Danaher Corporation (Beckman Coulter)
9.6.9 bioMérieux S.A.
9.6.10 Abcam plc
9.6.11 Enzo Life Sciences, Inc.
9.6.12 R&D Systems (Bio-Techne)
9.6.13 Eurofins Scientific
9.6.14 ZEUS Scientific, Inc.
9.6.15 BioLegend, Inc.
9.6.16 Creative Diagnostics
9.6.17 Grifols
9.6.18 Dynex Technologies
9.6.19 Berthold Technologies
9.6.20 Tecan Group Ltd.
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 ELISA Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions on ELISA Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
Get in Touch
